Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
14
5
5
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
21.4%
3 terminated/withdrawn out of 14 trials
57.1%
-29.4% vs industry average
36%
5 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Impact of IBD Activity on Frailty in Patients Over 60 Years
Role: lead
Immunological Characteristics of Preclinical IBD
Role: lead
Immunosuppressant Discontinuation in Elderly Patients With Ulcerative Colitis And Long-term Remission
Role: lead
Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU
Role: lead
Impact of Therapeutic Intervention on Quality of Life in Patients With Ulcerative Colitis
Role: lead
Prospective Multicenter Randomized Comparative Study of the Treatment of de Novo Stenosis in Chron's Disease.
Role: lead
Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis
Role: lead
An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)
Role: lead
A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease
Role: lead
Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)
Role: lead
Comparative Prospective Multicenter Randomized Study of Endoscopic Treatment of Stenosis in Crohn´s Disease
Role: lead
Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants
Role: lead
Efficacy Study of Granulocytapheresis Plus Steroids vs Steroids Alone in Active Steroid Dependant Ulcerative Colitis
Role: lead
Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease
Role: lead
All 14 trials loaded